Description: Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Home Page: www.boiron.fr
2, avenue de l’Ouest Lyonnais
Messimy,
69510
France
Phone:
33 4 78 45 61 00
Officers
| Name | Title |
|---|---|
| Mr. Thierry Boiron | GM & Director |
| Mr. Eric Lambert | Secretary General and Chief Financial & Administrative Officer |
| Mr. Patrice Varraut | Director of Operations |
| Ms. Juliette Baudry | Human Resources Director |
| Mr. Jean-Christophe Bayssat | Deputy GM, Chief Pharmacist & Director of Pharmaceutical Development |
| Mr. Fabrice Rey | Group Treasurer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 15.4083 |
|---|---|
| Trailing PE: | 20.0368 |
| Price-to-Book MRQ: | 1.2686 |
| Price-to-Sales TTM: | 0.9912 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2788 |